OncoSignal

Carlos Rodriguez-Galindo

St. Jude Children's Research Hospital · North American Consortium for Histiocytosis · Children's Oncology Group

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
9
all conditions, ClinicalTrials.gov
NIH grants tied to them
2
NIH RePORTER
Trial papers
42
PubMed author-name match

Trials

Studies that name Carlos Rodriguez-Galindo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:50 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:50 UTC. The ranking covers the 200 most relevant of 42 PubMed records, and a shared surname and initials can bring in a namesake. All 42 on PubMed

  1. 268 citations
    RCR 8.3
  2. 111 citations
    RCR 3.1
  3. 106 citations
    RCR 2.8
  4. 103 citations
    RCR 3.7
  5. 98 citations
    RCR 3.4
  6. 88 citations
    RCR 2.4
  7. 80 citations
    RCR 2.6
  8. 80 citations
    RCR 3.9
  9. 78 citations
    RCR 5.6
  10. 64 citations
    RCR 1.5